<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02878668</url>
  </required_header>
  <id_info>
    <org_study_id>ZS-LWH-2016</org_study_id>
    <nct_id>NCT02878668</nct_id>
  </id_info>
  <brief_title>The Value of Infectious Biomarkers for Prediction of Complication After Hepatopancreatobiliary Surgery</brief_title>
  <official_title>The Predictor of Infectious Complication After Hepatopancreatobiliary Surgery and Monitoring Indicator of Anti-infectious Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Harbin Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Zhongshan Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post operative complication after hepatopancreatobiliary surgery is high as 30-50%，which is
      the main reason for patient admitted to ICU. Several biomarkers have been shown to be useful
      in the early diagnosis of sepsis and systemic bacterial infection. The purpose of this study
      is to assess the predictive value of biomarkers for early complication after
      hepatopancreatobiliary surgery and assess the effectiveness of anti-infectious therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative complication after major abdominal surgery, such as pancreatic surgery and
      hilar cholangiocarcinoma surgery, is higher, up to 30 to 50%.It is the mainly reason for the
      patient to admit to ICU. Among this, the most common and difficult to handle complication is
      mainly anastomotic fistula, abdominal effusion and subsequent secondary infection. Delayed
      diagnosis can cause systemic inflammatory response syndrome (SIRS), multiple organ failure (
      MODS), and even death. From a surgical point of view, it leads to surgical failure and often
      need the second surgery. However, the diagnosis and treatment of postoperative infection is
      also facing two problems: it is difficult to confirm the diagnosis and make treatment
      decision. Hence, there is a strong need of an additional tool to early diagnose post
      operative complication.

      Serum procalcitonin (PCT), is a 116 amino-acids protein produced by C-cells of the thyroid
      gland. PCT baseline levels are low (&lt;0.05 ng/ml), but increase significantly in patients with
      severe bacterial infections. Therefore, PCT levels are used to monitor the course and
      prognosis of systemic bacterial infections and to tailor the therapeutic interventions more
      efficiently. Furthermore, PCT could serve as an early predictive marker for the clinical
      course of septic complications after abdominal surgery. The aim of this study is to
      demonstrate if PCT is a more sensible, specific and reliable biomarker of post operative
      complication than other biomarkers

      The investigators conducted a observational, prospective study. All patients undergoing
      electively hepatopancreatobiliary surgery in seven centres are recruited. In all cases white
      blood count (WBC), C-reactive protein (CRP) and PCT levels are measured in 1st, 3rd and 5th
      postoperative day (POD). Informed consent was obtained in all patients.The study is approved
      by the hospital's Ethical Committee.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>post operative complication</measure>
    <time_frame>within the first 30 days after he operation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>sepsis</measure>
    <time_frame>within the first 30 days after he operation</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Post-operative Complication</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>hepatopancreatobiliary surgery</intervention_name>
    <description>hepatopancreatobiliary surgery</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        1000 elective hepatopancreatobiliary sugery hospitalized patients will be included
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; = 18 years

          -  Hospitalized patients with elective hepatopancreatobiliary surgery

        Exclusion Criteria:

          -  age &lt;18 years

          -  emergency operative patients

          -  Preoperative fever, white blood cell elevation and preoperative infection

          -  Systemic inflammatory disease

          -  renal failure

          -  hematology disease

          -  preoperative abnormal PCT, IL-6, IL-8, CRP

          -  Laparoscopic cholecystectomy

          -  Bile duct infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wenhui Lou, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Zhongshan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wenhui Lou, MD</last_name>
    <phone>021-64041990</phone>
    <phone_ext>3450</phone_ext>
    <email>wenhuilou@aliyun.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wenchuan Wu, MD</last_name>
    <phone>021-64041990</phone>
    <phone_ext>2909</phone_ext>
    <email>wu.wenchuan@zs-hospital.sh.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Friendship hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhongtao Zhang, MD</last_name>
    </contact>
    <investigator>
      <last_name>Zhongtao Zhang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wei Guo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jiegao Zhu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sun Yat-Sen Memorial Hospital，Sun Yat-Sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yajin Chen, MD</last_name>
    </contact>
    <investigator>
      <last_name>Yajin Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jun Cao, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The first affiliated hospital of Harbin Medical University</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bei Sun, MD</last_name>
    </contact>
    <investigator>
      <last_name>Bei Sun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xuewei Bai, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jiangsu Province Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kuirong Jiang, MD</last_name>
    </contact>
    <investigator>
      <last_name>Kuirong Jiang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jishu Wei, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhongshan Hospital, Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenhui Lou, MD</last_name>
      <phone>021-64041990</phone>
      <phone_ext>3450</phone_ext>
      <email>wenhuilou@aliyun.com</email>
    </contact>
    <contact_backup>
      <last_name>Wenchuan Wu, MD</last_name>
      <phone>021-64041990</phone>
      <phone_ext>2909</phone_ext>
      <email>wu.wenchuan@zs-hospital.sh.cn</email>
    </contact_backup>
    <investigator>
      <last_name>Wenhui Lou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wenchuan Wu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yuan Fang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Changhai Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gang Jin, MD</last_name>
    </contact>
    <investigator>
      <last_name>Gang Jin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kailian Zheng, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West China Hospital, Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xubao Liu, MD</last_name>
    </contact>
    <investigator>
      <last_name>Xubao Liu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hao Zhang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993 Feb 27;341(8844):515-8.</citation>
    <PMID>8094770</PMID>
  </reference>
  <reference>
    <citation>Mofidi R, Suttie SA, Patil PV, Ogston S, Parks RW. The value of procalcitonin at predicting the severity of acute pancreatitis and development of infected pancreatic necrosis: systematic review. Surgery. 2009 Jul;146(1):72-81. doi: 10.1016/j.surg.2009.02.013. Epub 2009 May 8. Review.</citation>
    <PMID>19541012</PMID>
  </reference>
  <reference>
    <citation>Rau BM, Frigerio I, Büchler MW, Wegscheider K, Bassi C, Puolakkainen PA, Beger HG, Schilling MK. Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg. 2007 Feb;142(2):134-42.</citation>
    <PMID>17309964</PMID>
  </reference>
  <reference>
    <citation>Novotny AR, Emmanuel K, Hueser N, Knebel C, Kriner M, Ulm K, Bartels H, Siewert JR, Holzmann B. Procalcitonin ratio indicates successful surgical treatment of abdominal sepsis. Surgery. 2009 Jan;145(1):20-6. doi: 10.1016/j.surg.2008.08.009. Epub 2008 Sep 26.</citation>
    <PMID>19081471</PMID>
  </reference>
  <reference>
    <citation>Limper M, de Kruif MD, Duits AJ, Brandjes DP, van Gorp EC. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect. 2010 Jun;60(6):409-16. doi: 10.1016/j.jinf.2010.03.016. Epub 2010 Mar 27. Review.</citation>
    <PMID>20347867</PMID>
  </reference>
  <reference>
    <citation>Tavares E, Maldonado R, Ojeda ML, Miñano FJ. Circulating inflammatory mediators during start of fever in differential diagnosis of gram-negative and gram-positive infections in leukopenic rats. Clin Diagn Lab Immunol. 2005 Sep;12(9):1085-93.</citation>
    <PMID>16148175</PMID>
  </reference>
  <reference>
    <citation>Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA. The neutrophil as a cellular source of chemokines. Immunol Rev. 2000 Oct;177:195-203. Review.</citation>
    <PMID>11138776</PMID>
  </reference>
  <reference>
    <citation>Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13.</citation>
    <PMID>15273542</PMID>
  </reference>
  <reference>
    <citation>DeOliveira ML, Winter JM, Schafer M, Cunningham SC, Cameron JL, Yeo CJ, Clavien PA. Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg. 2006 Dec;244(6):931-7; discussion 937-9.</citation>
    <PMID>17122618</PMID>
  </reference>
  <reference>
    <citation>Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M; International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005 Jul;138(1):8-13. Review.</citation>
    <PMID>16003309</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 22, 2016</study_first_submitted>
  <study_first_submitted_qc>August 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2016</study_first_posted>
  <last_update_submitted>August 24, 2016</last_update_submitted>
  <last_update_submitted_qc>August 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Zhongshan Hospital</investigator_affiliation>
    <investigator_full_name>Wenhui Lou</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>procalcitonin</keyword>
  <keyword>post-operative</keyword>
  <keyword>complication</keyword>
  <keyword>CRP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infection</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

